Skip to main content

Rasagiline

NDC 83085-007 · SKG Pharma Inc.

Generic nameRasagiline mesylate
Dosage formTABLET
RouteORAL
Active ingredient(s)RASAGILINE MESYLATE
Strength.5 mg/1
Pharmacologic classMonoamine Oxidase Inhibitor [EPC], Monoamine Oxidase Inhibitors [MoA]
Marketing categoryANDA

Packages

83085-007-10 — 1000 TABLET in 1 BOTTLE (83085-007-10)

83085-007-30 — 30 TABLET in 1 BOTTLE (83085-007-30)

83085-007-50 — 500 TABLET in 1 BOTTLE (83085-007-50)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

42571-221 — Rasagiline, 47781-683 — Rasagiline, 47781-690 — Rasagiline, 51407-008 — Rasagiline mesylate, 51407-009 — Rasagiline mesylate, 62135-676 — Rasagiline, 62135-677 — Rasagiline, 64980-711 — Rasagiline mesylate, 64980-712 — Rasagiline mesylate, 67877-259 — Rasagiline, 67877-260 — Rasagiline, 68546-142 — Rasagiline mesylate, 68546-229 — Rasagiline mesylate, 70518-4683 — Rasagiline, 71921-407 — Rasagiline mesylate, 71921-408 — Rasagiline mesylate, 72162-2383 — Rasagiline, 80005-141 — Rasagiline mesylate, 80005-142 — Rasagiline mesylate, 83085-008 — Rasagiline mesylate, +9 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels